Medtronic (MDT) Stock Analysis & Winston Score
Medtronic makes medical devices — tools and machines that doctors use to treat patients. Its products include pacemakers (devices that help hearts beat correctly), insulin pumps for diabetes patients, spinal implants, and surgical robots. Hospitals and doctors around the world are its main customers, making Medtronic one of the largest medical device companies on the planet. Medtronic earns money by selling its devices and the supplies that go with them, like catheters and sensors that need regular replacement. It operates in over 150 countries, with roughly half its revenue coming from outside the United States. The company's size gives it an advantage — it has deep relationships with hospitals and a large sales force that smaller competitors struggle to match. The biggest challenge Medtronic faces is that several of its core markets, like cardiac devices, are mature and growing slowly, so the company is betting on newer areas like surgical robotics and diabetes technology to drive future growth.
Winston Score: 58/100 — Good
A decent business — some strong pillars, some weaker.
- Quality: Good (15/30)
- Growth: Strong (16/20)
- Cash Flow: Exceptional (9/10)
- Stability: Strong (8/10)
- Valuation: Strong (7/10)
- Ownership: Weak (1/15)
Key Facts
Price: $83.20
Market Cap: $106.5B
Sector: Healthcare
Industry: Medical - Devices


